Der p 11 Is a Major Allergen for House Dust Mite-Allergic Patients Suffering from Atopic Dermatitis  by Banerjee, Srinita et al.
Der p 11 Is a Major Allergen for House Dust
Mite-Allergic Patients Suffering from Atopic Dermatitis
Srinita Banerjee1, Yvonne Resch1, Kuan-Wei Chen1, Ines Swoboda1,2,14, Margit Focke-Tejkl2, Katharina Blatt3,
Natalija Novak4, Magnus Wickman5, Marianne van Hage6, Rosetta Ferrara7,15, Adriano Mari7,15,
Ashok Purohit8, Gabrielle Pauli8, Elopy N. Sibanda9, Portia Ndlovu9, Wayne R. Thomas10, Vladislav Krzyzanek11,
Sebastian Tacke12, Ursula Malkus12, Peter Valent3, Rudolf Valenta1,2 and Susanne Vrtala1,13
House dust mites (HDMs) belong to the most potent indoor allergen sources worldwide and are associated with
allergic manifestations in the respiratory tract and the skin. Here we studied the importance of the high-
molecular-weight group 11 allergen from Dermatophagoides pteronyssinus (Der p 11) in HDM allergy. Sequence
analysis showed that Der p 11 has high homology to paramyosins from mites, ticks, and other invertebrates. A
synthetic gene coding for Der p 11 was expressed in Escherichia coli and rDer p 11 purified to homogeneity as
folded, alpha-helical protein as determined by circular dichroism spectroscopy. Using antibodies raised against
rDer p 11 and immunogold electron microscopy, the allergen was localized in the muscle beneath the skin of
mite bodies but not in feces. IgE reactivity of rDer p 11 was tested with sera from HDM-allergic patients from
Europe and Africa in radioallergosorbent test–based dot-blot assays. Interestingly, we found that Der p 11 is a
major allergen for patients suffering from atopic dermatitis (AD), whereas it is only a minor allergen for patients
suffering from respiratory forms of HDM allergy. Thus, rDer p 11 might be a useful serological marker allergen for
the identification of a subgroup of HDM-allergic patients suffering from HDM-associated AD.
Journal of Investigative Dermatology (2015) 135, 102–109; doi:10.1038/jid.2014.271; published online 25 September 2014
INTRODUCTION
House dust mites (HDMs) belong to the most important allergen
sources worldwide (Platts-Mills and Chapman, 1987; Thomas,
2011). Approximately 50% of allergic patients in Central
Europe below an altitude of 1500 m are sensitized to allergens
from HDM, which causes various allergic symptoms such as
allergic rhinoconjunctivitis, allergic asthma, and skin mani-
festations, in particular atopic dermatitis (AD; Platts-Mills and
Chapman, 1987; Platts-Mills et al., 2009; Thomas, 2011; Kim
et al., 2013). Several HDM allergens have been characterized
regarding their sequences, biochemical properties, and their
structures (Platts-Mills et al., 2009; Thomas et al., 2010; Thomas,
2011; Kim et al., 2013). However, only few allergens from
HDMs have been extensively characterized regarding their
IgE-binding frequencies, allergenic activities, clinical relevance,
and usefulness for diagnosis of HDM allergy in a systematic
manner (Lynch et al., 1997; Friedmann, 1999; Simpson et al.,
2003; Pittner et al., 2004; Weghofer et al., 2008a; Weghofer
et al., 2008b; Weghofer et al., 2008c; Resch et al., 2011).
Der p 11 and group 11 allergens, which occur in several
clinically important species of mites, belong to a family of
proteins known as paramyosins (Tsai et al., 1998; Ramos
et al., 2001; Tsai et al., 2005). Paramyosin, a muscle-
associated alpha-helical high-molecular-weight (B100 kDa)
molecule has been identified as an immunogenic protein in
invertebrates in attempts to develop a vaccine against parasites
(i.e., Schistosomes; Lanar et al., 1986). Available data suggest
that group 11 allergens may be important allergens (Tsai et al.,
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1998; Ramos et al., 2001; Ramos et al., 2003; Tsai et al.,
2005).
Here we expressed the group 11 allergen from Dermato-
phagoides pteronyssinus, Der p 11, in Escherichia coli,
purified the recombinant allergen, and performed a biochem-
ical, structural, and immunological comparison with the
natural allergen. Folded recombinant Der p 11 equaling IgE
reactivity of the natural allergen was then tested for IgE
reactivity in European and African populations of HDM-
allergic patients. This serological analysis and a stratification
of the HDM patients into patients suffering from only respira-
tory forms of HDM allergy and patients with HDM-associated
AD revealed that rDer p 11 may serve as a major diagnostic
marker allergen for HDM-allergic patients suffering from AD.
RESULTS
Paramyosins represent allergens with highly conserved primary
structure in HDMs, tropical mites, and skin parasites
When we searched in the NCBI database for proteins that are
homologous to Der p 11, we found a large number of related
paramyosins in invertebrates including arachnids, insects,
worms, crustaceans, and mollusks. Table 1 provides a com-
parison of the sequence identities of Der p 11 with selected
paramyosins from arachnids, insects, and worms. The highest
degree of sequence identity was found between Der p 11 and
paramyosins from HDM, tropical and itchy mites, skin para-
sites such as ticks and lice (465% sequence identity), as well
as paramyosins from insects. A lower sequence identity was
found between Der p 11 and paramyosins from worms,
mollusks, and crustaceans (Table 1, data not shown). Detailed
alignment of the amino acid sequence of Der p 11, with the
sequences of paramyosins from D. farinae, the tropical mite
Blomia tropicalis, the itchy mite Sarcoptes scabiei, ticks (Ixodes
scapularis), bee (Apis mellifera), and the worm Trichniella
spiralisis is shown in the Supplementary Figure S1 online. Der
p 11 is a protein of 874 amino acids with a deduced
molecular mass of B103 kDa, and it shows high sequence
identities (485% sequence identity) with paramyosins from
HDM, itchy mites, and tropical mites (Supplementary Figure
S1 online). All four predicted N-glycosylation sites and both of
the cysteine residues are conserved among paramyosins from
mites (Supplementary Figure S1 online).
Expression and purification of folded rDer p 11
rDer p 11 was purified to homogeneity by affinity chromato-
graphy and compared with purified natural Der p 11 (nDer p
11) by SDS-PAGE under reducing and nonreducing conditions
and subsequent silver staining (Figure 1a). Under nonreducing
conditions, natural as well as recombinant Der p 11 occurred
mainly as high-molecular-weight aggregates of more than
250 kDa. However, under reducing conditions, recombinant
and nDer p 11 migrate as bands of B100 kDa and several
smaller fragments in SDS-PAGE, which is in agreement with
the predicted molecular weight of complete monomeric Der p
11 (i.e.,B103 kDa) and degradation products (Figure 1a) (Tsai
et al., 2005). When purifying nDer p 11, we frequently
obtained preparations containing degradation products with
molecular weights o70 kDa (data not shown). A monoclonal
antibody specific for the hexahistidine tag (Dianova, Hamburg,
Germany) identified the fragments in the recombinant Der p
11 preparation as His-tagged proteins, which therefore are
derived from the C terminus of the protein (data not shown).
To characterize the Der p 11 fragments, peptide mass
fingerprinting was conducted using peptides from the
B65-kDa and 100-kDa bands in the rDer p 11 preparation
(Figure 1a). Sequences obtained from the B100-kDa poly-
peptide (* in Figure 1a), shown as open boxes in Supple-
mentary Figure S1 online, almost cover the whole sequence,
whereas the peptides from the 65-kDa fragment ( in
Figure 1a) shown as gray boxes are located at the carboxyl
terminal end of Der p 11 (Supplementary Figure S1 online).
Circular dichroism analysis was performed to determine the
secondary structure of Der p 11. It revealed two minima at
209 and 222 nm in the spectrum of rDer p 11 typical for a
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Figure 1. Purification of natural and recombinant Der p 11. (a) A molecular
mass marker (M) and 3mg of purified rDer p 11 and nDer p 11 were separated
by SDS-PAGE under reducing and nonreducing conditions and were silver
stained. rDer p 11 bands marked with an arrow were subjected to mass
spectrometry analysis. (b) Circular dichroism analysis. The molecular
ellipticities (y) (y axis) at different wavelengths (200–260 nm, x axis) are
displayed for rDer p 11 (gray) and nDer p 11 (black).
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predominant alpha-helical structure (Figure 1b). The spectrum
of nDer p 11 was very similar, but the minima were less
pronounced. Heating of rDer p 11 caused a shift of the curve
to the left, but even after heating the protein to 95 1C it still
exhibited alpha-helical fold and after cooling to 25 1C it
almost completely regained its original fold (data not shown).
Der p 11 occurs predominantly in the muscle of house dust mite
bodies but not in mite feces
Next we studied mite feces and mite body fractions for the
presence of Der p 11 using Der p 11-specific antibodies
(Figure 2a). Der p 11-specific antibodies reacted strongly with
moieties of 470 kDa in blotted mite body extracts but not in
mite feces extracts (Figure 2a). When we used anti-Der p 2
antibodies for control purposes, we could detect Der p 2 in the
mite body and mite feces extracts. No reactivity was observed
with the preimmune serum with any of the mite extracts
(Figure 2a). Next, we localized Der p 11 in the mite bodies
with immunogold electron microscopy. Anti-Der p 11 anti-
bodies specifically reacted to the muscle beneath the skin of
mites in ultrathin sections of mite bodies but not with the gut
nor with the feces, which fits to the role of paramyosin as a
locomotory muscle protein in invertebrates (Nisbet et al.,
2006; Figure 2b). Only a few gold particles were found with
the control antibodies, indicating the specificity of the binding
(Figure 2b).
IgE reactivity of rDer p 11
In a first series of experiments, we compared recombinant Der
p 11 with nDer p 11 regarding IgE reactivity, which showed
that both proteins exhibited comparable IgE binding in dot-
blot and western blot assays (data not shown). Therefore, we
used rDer p 11 for IgE reactivity studies and compared the IgE
reactivity of a random sample of HDM-allergic patients from
Zimbabwe with dot-blotted rDer p 11 and rDer p 2 (Figure 3a).
rDer p 11 reacted with fewer patients, and the IgE reactivity
was less pronounced than that of rDer p 2. None of the
HDM-allergic patients’ sera reacted with BSA, and serum from
a nonallergic person or buffer gave no reaction with any of the
dotted proteins.
Higher prevalence of IgE reactivity to Der p 11 in populations
comprising AD patients
We then studied the frequency of IgE recognition of Der p 11
using sera from HDM-allergic patients from several European
countries (Austria: n¼ 47, France: n¼38, Italy: n¼67, Swe-
den: n¼52) and from southern Africa (i.e., Zimbabwe: n¼ 34;
Figure 3b). In the European HDM-allergic patients, the
frequency of IgE reactivity to Der p 11 was relatively low
(Austria 13%, France 16%, Italy 7%, and Sweden 10%) when
compared with the major HDM allergen Der p 2 (Austria
98%, France 82%, Italy 94%, and Sweden 46%). In contrast,
44% of the HDM-allergic patients from Zimbabwe showed IgE
reactivity to Der p 11 and 71% to Der p 2 (Figure 3b).
Moreover, sera from the patients from Zimbabwe showed
much stronger IgE reactivity to Der p 11 than the European
patients (data not shown).
A careful analysis of the clinical symptoms of the HDM-
allergic patients from the different countries revealed that AD
was much more common in the African patients (i.e., 44%)
compared with the European patients (Austria: 15%, France:
18%, Italy: 0%, and Sweden: 0%). A detailed analysis of the
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frequency of IgE reactivity to Der p 11 in the African
population according to clinical symptoms showed that IgE
recognition of rDer p 11 was confined mainly to the AD
patients, with a prevalence of 54% in this subgroup.
rDer p 11 is a marker allergen for AD in HDM-allergic patients
To study whether IgE reactivity to rDer p 11 may indeed be
associated with AD, we analyzed sera from a well-defined
group of German patients suffering from HDM-associated AD
for IgE reactivity to rDer p 11 (Supplementary Table S1
online). In this analysis, we included also other HDM aller-
gens that occur in feces (i.e., nDer p 1, rDer p 2, rDer p 5,
rDer p 7, rDer p 21, rDer p 23) or in HDM bodies (i.e., Der p
10, rDer p 14, rDer p 18). For control purposes, sera from the
Austrian HDM-allergic patients were tested for IgE reactivity to
the same allergen panel.
Table 2 shows the frequencies of IgE reactivity to Der p 1,
Der p 2, Der p 5, Der p 7, Der p 21, Der p 23 (allergens in
mite feces), Der p 10, Der p 11, Der p 14, and Der p 18
(allergens in mite bodies) in the German AD population and in
the Austrian population, which was stratified in patients with
only respiratory or skin symptoms to HDM. Interestingly, rDer
p 11 was recognized by 55% of the German AD patients and
67% of the Austrian AD patients. Only 5% of the Austrian
patients suffering from respiratory allergy reacted with rDer p
11. The frequencies of IgE reactivity to allergens derived from
feces (i.e., nDer p 1, rDer p 2, rDer p 5, rDer p 7, rDer p 21,
rDer p 23) were similar in patients with AD and patients with
respiratory allergy (Table 2, underlined). The frequency of IgE
recognition of Der p 10, a muscle-derived allergen, similar to
Der p 11, which occurs only in mite bodies and not in feces
(Friedmann, 1999), was also higher in the patients suffering
from AD (German AD: 25%, Austrian AD: 67%) compared
with the Austrian patients with respiratory symptoms (i.e.,
10%; Table 2). Semiquantitative determination of IgE levels by
ImmunoCAP ISAC technology (Lupinek et al., 2014) showed
that IgE levels to AD-related allergens (i.e., Der p 11, Der p 10)
were much lower than toward respiratory allergens (i.e., Der p
1, Der p 2; data not shown). In addition, also other HDM
allergens, which were only found in mite bodies (i.e., Der p
Table 2. Frequencies of IgE recognition of HDM
allergens1
Austrian (n¼47) German
AD (%; n¼5) Respiratory (%; n¼ 42) AD (%; n¼ 100)
nDer p 1 100 76 82
rDer p 2 100 98 95
rDer p 5 33 41 39
rDer p 7 33 24 22
rDer p 10 67 10 25
rDer p 11 67 5 55
rDer p 14 67 2 23
rDer p 18 17 5 22
rDer p 21 33 37 30
rDer p 23 100 71 83
Abbreviation: AD, atopic dermatitis.
1Frequencies of IgE recognition of allergens occurring mainly in mite
bodies (Der p 10, Der p 11, Der p 14, Der p 18) or in mite feces (Der p 1,
Der p 2, Der p 5, Der p 7, Der p 21, Der p 23 underlined), in the German
AD population with HDM allergy and in the Austrian HDM-allergic
population stratified according to AD or only respiratory symptoms.
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14 and Der p 18), were more often recognized by HDM-
allergic patients with AD than by patients with respiratory
symptoms (Table 2).
DISCUSSION
We expressed in E. coli and purified Der p 11 as a folded
recombinant allergen. Purified rDer p 11 exhibited predomi-
nantly alpha-helical structure, as it has been shown for other
invertebrate paramyosins (Lanar et al., 1986) and also for Der
p 10, which is another allergen derived from mite muscle
(Friedmann, 1999). The detailed comparison of the amino
acid sequence of Der p 11 with other invertebrate para-
myosins showed that it contains two cysteine residues that are
highly conserved in paramyosins from mites including the
tropical mite (B. tropicalis) and the skin ectoparasite S. scabiei.
The formation of intermolecular disulfide bonds in fact
explains why recombinant as well as nDer p 11 formed
aggregates under nonreducing conditions. A comparison of
recombinant Der p 11 with nDer p 11 regarding IgE reactivity
showed that both proteins exhibited comparable IgE binding
(data not shown). Therefore, rDer p 11 was used to study the
IgE-binding frequency in several European and an African
population of HDM-allergic patients. Interestingly, this
analysis showed a big discrepancy regarding the frequencies
of IgE recognition in the European and African populations:
in the European countries, the IgE-binding frequencies
were rather low (Austria: 13%, France: 16%, Italy: 7%, and
Sweden: 10%), whereas in Africa the IgE reactivity of rDer p
11 was 44%. Initially, we considered that IgE cross-reactivity
of Der p 11 with paramyosins from other invertebrates (e.g.,
tropical mites, parasites), which are frequent in Africa, could
be the reason for this unexpected high prevalence of IgE
recognition in the African population. However, testing of
extracts made from tropical mites and parasites with Der p
11-specific antibody probes (data not shown) spoke against
this possibility and, moreover, the African patients used in this
study had no parasitic infections.
A detailed analysis of the clinical documentation of the
patients from Europe and Africa revealed a much higher
prevalence of HDM-associated AD in the African patients as
compared with the European populations and that IgE reac-
tivity to rDer p 11 was mainly confined to patients suffering
from HDM-associated AD but was rare in patients suffering
only from HDM-associated respiratory allergy.
To study whether IgE reactivity to Der p 11 is indeed
associated with AD, we analyzed another group of European
patients suffering from HDM-associated AD and found that
55% of these patients showed IgE reactivity with rDer p 11.
Furthermore, when IgE reactivity to Der p 11 was analyzed
separately in Austrian patients with HDM-associated AD or
only respiratory forms of HDM allergy, a similar result was
found. rDer p 11 was recognized by 67% of the AD patients
but only from 5% of the patients with respiratory allergy.
Another interesting finding was that another allergen asso-
ciated with mite muscles, i.e., tropomyosin (Der p 10), was
more frequently recognized by AD patients than by patients
with respiratory allergy to HDM. On the other hand, the IgE
recognition frequency of allergens present mainly in mite
feces (i.e., Der p 1, Der p 2, Der p 5, Der p 7, Der p 21, and
Der p 23) was comparable in patients with HDM-associated
AD and respiratory allergy to HDM.
The latter findings are interesting, because they suggest that
there may be different routes of sensitization toward certain
HDM allergens: Mite feces have been identified as a major
source for many important mite allergens (Tovey et al., 1981);
however, together with Der p 10, Der p 14, and Der p 18, Der
p 11 is one of the few HDM allergens that occurred primarily
in the mite bodies but was absent from mite feces, as demon-
strated by immunoblotting of protein extracts obtained from
mite bodies and feces and by in situ immunogold electron
microscopy. It is thus possible that patients become sensitized
toward Der p 11 and other mite body–associated allergens by
skin contact. In this context, it has been found that epicuta-
neous sensitization to protein antigens indeed can induce
allergic sensitization and even may enhance subsequent res-
piratory allergy toward the same antigen (Spergel et al., 1998;
Beck and Leung, 2000; He et al., 2009). In an experimental
dog model of acute AD, epicutaneous application of HDM
extracts destroyed the skin barrier function by reduction of
stratum corneum ceramides (Stahl et al., 2012). It is also well
established that genetically inherited defects affect the skin
barrier function (McLean and Irvine, 2012). Furthermore, it is
possible that allergic inflammation in the skin may reduce skin
barrier (De Benedetto et al., 2012; Agrawal and Woodfolk,
2014). Thus, there are at least three possible mechanisms of
how impaired skin barrier function in AD could facilitate
sensitization to allergens via the skin.
In summary, our study reveals that rDer p 11 is a major
marker allergen for HDM-allergic patients suffering from AD.
Allergen-specific immunotherapy has been shown to be
effective also for the treatment of AD (Novak et al., 2012).
As Der p 11 seems to be a major allergen for patients with
HDM-associated AD, it needs to be considered as a
component of specific immunotherapy preparations for this
group of patients.
MATERIALS AND METHODS
Sequence comparison of Der p 11 with paramyosins, expression
of rDer p 11, and purification of natural and recombinant Der p
11
The Der p 11 amino acid sequence was compared with sequences
deposited in the NCBI database using basic local alignment search
tool (http://blast.ncbi.nlm.nih.gov/), and the extent of sequence identity
of Der p 11 with the homologous proteins was determined using the
multiple sequence alignment program (ClustalW). A detailed seq-
uence alignment of Der p 11 with six sequences from invertebrates
belonging to different phyla of invertebrates was performed to
investigate the conservation of particular sequence features.
A synthetic gene coding for Der p 11 (GenBank accession number
AY189697) with codons optimized for expression in E. coli was
synthesized with six histidine codons at the 30 end and inserted into
plasmid pET-17b (Novagen, Madison, WI) at the NdeI/EcoRI site
(ATG:biosynthetics, Merzhausen, Germany). rDer p 11 was expressed
in E. coli BL21(DE3) (Stratagene, Santa Clara, CA), as described (Chen
et al., 2008). rDer p 11 was found in the inclusion body fraction and
purified over Ni-NTA resin (Qiagen, Hilden, Germany), as described
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(Chen et al., 2008). Fractions containing rDer p 11 of more than 90%
purity were pooled and urea was removed by stepwise dialysis
against 10 mmol l 1 NaH2PO4 (pH 8).
nDer p 11 was purified by affinity chromatography from a HDM
extract using rabbit anti-rDer p 11 antibodies (Friedmann, 1999) and
eluted with 10 ml of 5 mM glycine and 50% ethylene glycol, pH 11
(Ramos et al., 2003). Eluted nDer p 11 fractions were pooled and
dialyzed against 10 mmol l 1 NaH2PO4 (pH 8) and then frozen at
 20 1C until use.
Biochemical and structural characterization of rDer p 11 and
nDer p 11
The purity of rDer p 11 and nDer p 11 was determined by SDS-PAGE
and silver staining, and their concentrations were measured using the
Micro BCA Assay Kit (Pierce, Rockford, IL). To study the behavior of
rDer p 11 and nDer p 11 under reducing and nonreducing conditions,
the proteins were separated by SDS-PAGE using an SDS buffer with or
without b-mercaptoethanol and were silver stained (Shevchenko
et al., 1996).
Bands in the rDer p 11 preparation were characterized by mass
spectrometry. For this purpose, protein bands with molecular weights
ofB100 kDa andB65 kDa were excised from SDS gels and digested
overnight at 37 1C with trypsin (Sigma, St Louis, MO). The digested
proteins were then subjected to mass spectrometry on a Nano-LC
system coupled to Bruker HCT Ultra ESI trap (Bruker Daltonics,
Bremen, Germany). The peptides were fractionated on a C18 PepMap
100 column (3 mm, 100 A1; LC Packings, Dionex, Sunnyvale, CA)
using a 5–80% acetonitrile solvent gradient. During elution, the mass
spectra were recorded in the mass/charge range of 300–3,000. Data
were processed using DataAnalysisTM 3.4 (Bruker Daltonics), and the
peak list generated was searched against the Swiss-Prot database
using MASCOT (Matrix Science, Boston, MA) search engine, which
identifies proteins from primary sequence databases. The search setting
included a missed cleavage site value of three, carboxymethylation of
cysteine and variable oxidation of methionine, histidine, and trypto-
phan. Protein matches with scores 450 indicated relevant identity to
known proteins (Po0.05).
The prediction of the secondary structure of Der p 11 was
performed with the PSIPRED program (http://bioinf.cs.ucl.ac.uk/psi-
predtest). CD spectra of purified rDer p 11 and nDer p 11 were
measured on a JASCO (Tokyo, Japan) J-810 spectropolarimeter as
described (Chen et al., 2008). The secondary structure content of rDer
p 11 and nDer p 11 were calculated using the secondary structure
estimation program CDSSTR (Whitmore and Wallace, 2004).
CD spectra of rDer p 11 were also recorded on heating and cooling
the protein (25 1C, 55 1C, 85 1C, 95 1C) to investigate the heat
denaturation and refolding behavior of the protein.
Patients’ sera, allergen-specific antibodies, purified allergens
Sera from HDM-allergic patients from four European countries
(Austria: n¼ 47, mean age: 33 years; France: n¼ 38, mean age: 36
years; Italy: n¼ 67, mean age: 22 years; Sweden: n¼ 52, mean age:
41 years) and from Africa (Zimbabwe: n¼ 34, mean age: 24 years)
were used in this study after informed written consent was provided.
Diagnosis of HDM allergy was based on case history, skin prick test
results, and/or the presence of D. pteronyssinus-specific IgE
(40.7 kUA l 1) determined with the ImmunoCAP System (Thermo-
fisher, Uppsala, Sweden). For the patients used in this study, clinical
documentation of HDM-associated symptoms (i.e., respiratory and/or
skin symptoms) was available. Sera from a group of patients suffering
from AD and sensitization to HDM (Germany: n¼ 100, mean age 15
years, mean total IgE: 1121 kU l 1) were used for an extensive
analysis of the prevalence of IgE reactivity to rDer p 11 in patients
with AD (Supplementary Table S1 online). Serum from a nonallergic
individual was used as a negative control in IgE-binding assays. Sera
were used with the approval of the local ethics committee.
Rabbit anti-sera specific for Der p 11 were obtained by immunizing
rabbits three times with the purified recombinant allergen using
Freund’s complete adjuvant once and Freund’s incomplete adjuvant
twice (Charles River, Kisslegg, Germany; Chen et al., 2008). nDer p 1
was isolated by affinity chromatography, as described (Hales et al.,
2000). Recombinant Der p 2, Der p 14, and Der p 18 were expressed
in E. coli with a C-terminal hexa-histidine tag using the pET-17b
expression system (Novagen) and purified by Ni-NTA agarose
(Qiagen; Chen et al., 2008). Recombinant Der p 5, Der p 7, Der p
10, Der p 21, and Der p 23 were expressed in E. coli as nonfusion
proteins and purified as described (Weghofer et al., 2008a; Weghofer
et al., 2008b; Resch et al., 2011; Weghofer et al., 2013).
Natural mite extracts and immunoblot analysis
Aliquots of 0.3 g of purified D. pteronyssinus whole bodies (Allergon,
Va¨llinge, Sweden) or feces (kind contribution from Ferna´ndez-Caldas
E, Inmunotek S.L., Madrid, Spain) were homogenized in 5 ml of SDS
buffer (62.8 mM Tris, 2.3% SDS, 10% glycerin, 5% b-mercaptoetha-
nol, and 1% bromophenol blue, pH 6.8) or 5 ml of 1 phosphate
buffer saline, pH 7, containing 1 mM phenylmethylsulfonyl fluoride,
respectively, using an Ultra-Turrax T25 Basic disperser (IKA, Staufen,
Germany). The homogenates were extracted overnight at 4 1C, and
the insoluble fractions were removed by centrifugation (20 minutes,
3,220 g, 4 1C). The quality of the extracts was analyzed by SDS-PAGE
and Coomassie brilliant blue staining (Towbin et al., 1979; Fling and
Gregerson, 1986). Equal amounts of each extract according to
Coomassie brilliant blue staining were separated by 14% SDS-
PAGE and blotted onto nitrocellulose. Membranes were incubated
with rabbit anti-rDer p 2 (1:100,000 in gold buffer), anti-rDer p 11
antibodies (1:10,000 in gold buffer), and the preimmune serum of the
Der p 11–immunized rabbit (1:10,000 in gold buffer) overnight at
4 1C. Bound antibodies were detected as described (Valenta et al.,
1992).
Immunogold electron microscopy
Anti-Der p 11 IgG antibodies were purified by affinity chromatogra-
phy (ImmunoPure IgG Purification Kit; Pierce) from the serum of an
rDer p 11-immunized rabbit. Rabbit preimmune IgG antibodies were
used for control purposes. Rabbit anti-Der p 11 IgG and the control
antibodies were used for immunogold electron microscopy as
described (Weghofer et al., 2008b).
IgE reactivity of Der p 11
For nondenaturing dot-blot assays, aliquots of 2ml containing 0.5mg
of rDer p 2, rDer p 11, and BSA were dotted onto nitrocellulose
membranes (Schleicher & Schuell, Dassel, Germany). For a more
detailed analysis of IgE reactivity in the German AD population and
the Austrian population, nDer p 1, rDer p 5, rDer p 7, rDer p 10, rDer
p 14, rDer p 18, rDer p 21, and rDer p 23 were included in the
allergen panel. Dot-blot analysis was performed as described (Chen
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et al., 2008). Semiquatitative determination of IgE levels to HDM
allergens was also performed by ImmunoCAP ISAC technology
(Lupinek et al., 2014).
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